Jump to full article: Lung Cancer Alliance, 2008-03-26
Intro: Today the New York Times ran an article "exposing" a donation made in 2000 by the Vector Group, which owns Liggett, to the International Early Lung Cancer Action Program (I-ELCAP) screening study and insinuated that the research and researchers were tainted.
Sadly, this is far from the truth and another attempt to discredit I-ELCAP and lung cancer screening in general. Why else raise this now? The donation was made 8 years ago, was publicly reported and was an unrestricted grant that allowed for no control by the donor. . . .
LCA President and CEO, Laurie Fenton Ambrose responded to the NY Times reporter with a written letter (below). We will not let those who want to deny the lung cancer community the benefits they deserve defeat our efforts. . . .
"I continue to be concerned that lost in these various questions and comments is any understanding of the public health epidemic upon us. Lung cancer is the most lethal of all cancers - killing more people than breast, prostate, colon, liver , kidney and melanoma cancers combined - 85% of which are current and former smokers - most of whom will die within a year of diagnosis because their cancers are found too late. We can help those at high risk for lung cancer today through the use of CT scans - and we stand proudly with those in the public health community who view lung cancer as a disease deserving of increased compassion and support."
--Laurie Fenton-Ambrose
Jump to full article » |